Human Papillomavirus Vaccine Safety in Pediatric Patients: An Evaluation of the Vaccine Adverse Event Reporting System

被引：12
|
作者：
Borja-Hart, Nancy L. [1 ]
Benavides, Sandra [1 ]
Christensen, Crystal [1 ]
机构：
[1] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33328 USA
来源：
ANNALS OF PHARMACOTHERAPY | 2009年 / 43卷 / 02期
关键词：
Gardasil; human papillomavirus; pediatrics; VAERS; PARTICLE VACCINE; QUADRIVALENT VACCINE; UNITED-STATES; TYPE-16; IMMUNOGENICITY; ADOLESCENTS; TRIAL; WOMEN;
D O I：
10.1345/aph.1L492
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Recent news reports have linked the human papillomavirus (HPV) vaccine to serious adverse events (AEs) in children and adolescents. We used the Vaccine Adverse Event Reporting System (VAERS) database to extract postmarketing AEs reported in patients who received the vaccine. Since approval of the HPV vaccine in the US, 3174 AEs occurring in children and adolescents (aged 6-17 y) have been reported to the VAERS. Of these, 191 (6%) were deemed to be serious. Although these AEs are of significant concern, more research is required before they can be directly correlated with the vaccine.
引用
收藏
页码：356 / 359
页数：4
相关论文
共 50 条
  • [1] Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System
    Moro, Pedro L.
    Zhang, Bicheng
    Marquez, Paige
    Reich, Jonathan
    JOURNAL OF PEDIATRICS, 2023, 262
  • [2] The vaccine adverse event reporting system and vaccine safety research in the genomics era
    Davis, Robert Lowell
    VACCINE, 2012, 30 (06) : 1162 - 1164
  • [3] Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
    Shimabukuro, Tom T.
    Nguyen, Michael
    Martin, David
    DeStefano, Frank
    VACCINE, 2015, 33 (36) : 4398 - 4405
  • [4] Safety Surveillance of Bivalent Meningococcal Group B Vaccine, Vaccine Adverse Event Reporting System, 2014-2018
    Duffy, Jonathan
    Marquez, Paige
    Dores, Graca M.
    Ng, Carmen
    Su, John
    Cano, Maria
    Perez-Vilar, Silvia
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (12):
  • [5] Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
    David A. Geier
    Mark R. Geier
    Immunologic Research, 2017, 65 : 46 - 54
  • [6] Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
    Woo, Emily Jane
    Moro, Pedro L.
    Cano, Maria
    Jankosky, Christopher
    VACCINE, 2017, 35 (42) : 5618 - 5621
  • [7] Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017
    Landazabal, Claudia S.
    Moro, Pedro L.
    Lewis, Paige
    Omer, Saad B.
    VACCINE, 2019, 37 (09) : 1229 - 1234
  • [8] Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database
    Geier, David A.
    Geier, Mark R.
    IMMUNOLOGIC RESEARCH, 2017, 65 (01) : 46 - 54
  • [9] MONITORING VACCINE SAFETY BY STUDYING TEMPORAL VARIATION OF ADVERSE EVENTS USING VACCINE ADVERSE EVENT REPORTING SYSTEM
    Huang, Jing
    Cai, Yi
    Du, Jingcheng
    Li, Ruosha
    Ellenberg, Susan S.
    Hennessy, Sean
    Tao, Cui
    Chen, Yong
    ANNALS OF APPLIED STATISTICS, 2021, 15 (01) : 252 - 269
  • [10] Internet-Based Reporting to the Vaccine Adverse Event Reporting System: A More Timely and Complete Way for Providers to Support Vaccine Safety
    Haber, Penina
    Iskander, John
    Walton, Kimp
    Campbell, Scott R.
    Kohl, Katrin S.
    PEDIATRICS, 2011, 127 : S39 - S44
12345